人工智能与感染病诊断:现状与未来展望
本文综述人工智能(AI)在感染病诊断中的应用现状,涵盖病原检测、抗菌药物管理与治疗监测,并指出AI在应对抗菌药物耐药方面的作用。文章分析高收入国家数据碎片化与算法偏倚、中低收入国家数字基础设施不足等障碍,呼吁协调投资与数据共享框架。
要点
- AI可提升病原检测、抗菌药物管理与治疗监测的准确性和效率。
- AI在快速病原鉴定与个体化治疗方面对遏制耐药意义显著。
- 数据碎片化、算法偏倚与基础设施差距阻碍AI公平落地。
核心结论
- AI有望改善感染病检测、预防与管理,但需协调投资数字基础设施、统一数据共享框架并促进临床医生参与,以实现公平可持续应用。
研究设计与样本
- 综述类:检索范围未在原文摘要中报告。
主要发现
- AI支持临床决策、优化实验室与临床流程并实现实时疾病监测。
- AI提升病原检测、抗菌药物管理与治疗监测的诊断准确性、效率与可扩展性。
- AI在对抗抗菌药物耐药方面作用显著,可实现快速病原鉴定与个体化治疗。
- 高收入国家面临数据生态碎片化、数据集不完整与算法偏倚,阻碍临床整合。
- 中低收入国家面临数字基础设施有限、数据不标准化与财务约束,加剧诊断可及性差距。
临床怎么用
- 临床可将AI用于辅助病原检测、抗菌药物管理与治疗监测,但需关注数据质量与算法偏倚。
- 落地前应评估互操作性、数据隐私、网络安全与AI监管要求。
局限性
- 原文指出互操作性、数据隐私、网络安全与AI实施监管是进一步障碍。
- 高收入与中低收入国家分别存在数据生态碎片化与数字基础设施不足等限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence (AI) is reshaping infectious disease diagnostics by supporting clinical decision making, optimising laboratory and clinical workflows, and enabling real-time disease surveillance. AI approaches improve pathogen detection, antimicrobial stewardship, and treatment monitoring, enhancing diagnostic accuracy, efficiency, and scalability. The role of AI in combating antimicrobial resistance is particularly significant, enabling rapid pathogen identification and personalised treatment. Despite progress over the past two decades, widespread AI adoption in infectious disease diagnostics faces challenges. In high-income countries, fragmented data ecosystems, incomplete datasets, and algorithmic bias hinder clinical integration. Meanwhile, low-income and middle-income countries contend with limited digital infrastructure, unstandardised data, and financial constraints, exacerbating disparities in diagnostic access. Further barriers include concerns over interoperability, data privacy, cybersecurity, and the regulation of AI implementation. This paper examines the role of AI in infectious disease diagnostics, highlighting both opportunities and limitations. It underscores the need for coordinated investments in digital infrastructure, harmonised data-sharing frameworks, and clinician engagement to support equitable, sustainable adoption. Addressing these challenges will enable health-care systems to harness the potential of AI to improve infectious disease detection, prevention, and management of infectious diseases, thereby strengthening global health resilience.
引用
- Miglietta L, Rawson TM, Galiwango R, et al. Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives. Lancet Infect Dis. 2025. PMID: 40972627. doi:10.1016/S1473-3099(25)00354-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。